Table 5.

CYP1A1 haplotypes and endometrial cancer risk

Polymorphism
Cases (n = 371)
Controls (n = 420)
OR, age adjusted (95% CI)
m1m2m4nFrequencynFrequency
TIleThr3260.8803530.8411.00 (Reference)
TIleAsn170.046180.0431.10 (0.67-1.78)
CIleThr190.050320.0750.67 (0.45-1.01)
CValThr90.023170.0410.54 (0.30-0.97)